DE69425706D1 - Bakterium neuer Art und Verfahren zur Herstellung von Carotenoiden unter Verwendung dieses Bakteriums - Google Patents

Bakterium neuer Art und Verfahren zur Herstellung von Carotenoiden unter Verwendung dieses Bakteriums

Info

Publication number
DE69425706D1
DE69425706D1 DE69425706T DE69425706T DE69425706D1 DE 69425706 D1 DE69425706 D1 DE 69425706D1 DE 69425706 T DE69425706 T DE 69425706T DE 69425706 T DE69425706 T DE 69425706T DE 69425706 D1 DE69425706 D1 DE 69425706D1
Authority
DE
Germany
Prior art keywords
bacterium
new type
producing carotenoids
carotenoids
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69425706T
Other languages
English (en)
Other versions
DE69425706T2 (de
Inventor
Akira Tsubokura
Hisashi Yoneda
Mikihiro Takaki
Takashi Kiyota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Nippon Mitsubishi Oil Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Mitsubishi Oil Corp filed Critical Nippon Mitsubishi Oil Corp
Application granted granted Critical
Publication of DE69425706D1 publication Critical patent/DE69425706D1/de
Publication of DE69425706T2 publication Critical patent/DE69425706T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69425706T 1993-07-22 1994-07-22 Bakterium neuer Art und Verfahren zur Herstellung von Carotenoiden unter Verwendung dieses Bakteriums Expired - Lifetime DE69425706T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18161593 1993-07-22

Publications (2)

Publication Number Publication Date
DE69425706D1 true DE69425706D1 (de) 2000-10-05
DE69425706T2 DE69425706T2 (de) 2001-05-03

Family

ID=16103902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425706T Expired - Lifetime DE69425706T2 (de) 1993-07-22 1994-07-22 Bakterium neuer Art und Verfahren zur Herstellung von Carotenoiden unter Verwendung dieses Bakteriums

Country Status (5)

Country Link
US (2) US5607839A (de)
EP (1) EP0635576B1 (de)
CA (1) CA2128549C (de)
DE (1) DE69425706T2 (de)
NO (1) NO313204B1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2093008A1 (en) * 1990-10-01 1992-04-02 Charles H. Hennekens Beta-carotene and vitamin e therapy for inhibition of major vascular events
US5827652A (en) 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
ATE242812T1 (de) 1996-12-02 2003-06-15 Hoffmann La Roche Verbesserte fermentative herstellung von carotenoide
US5935808A (en) * 1997-07-29 1999-08-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Carotenoid-producing bacterial species and process for production of carotenoids using same
US6221918B1 (en) * 1999-09-05 2001-04-24 Siberian Center For Natural Technologies, Inc. Combination of carotenoids for use as dietary supplement or topical ointment
JP4463347B2 (ja) * 1999-09-30 2010-05-19 新日本石油株式会社 飼料添加用色素含有物
JP4427167B2 (ja) 2000-06-12 2010-03-03 新日本石油株式会社 カロテノイド色素の製法
DE10046838A1 (de) * 2000-09-20 2002-04-04 Henkel Kgaa Verwendung von Myxoxanthophyll und/oder Echinenon zur prophylaktischen und/oder therapeutischen Behandlung von unerwünschten, durch oxidative Prozesse bedingten oder begünstigten körperlichen Zuständen
US7691406B2 (en) * 2000-10-27 2010-04-06 ZeaVision LLC. Zeaxanthin formulations for human ingestion
DE10117303A1 (de) 2001-03-30 2002-10-31 Council Scient Ind Res Ein natürlicher Fluoreszenzfarbstoff, gewonnen aus einem marinen Invertebraten, Zusammensetzungen die diesen Farbstoff enthalten und ihre Verwendung
US6916492B2 (en) 2001-03-30 2005-07-12 Council Of Scientific & Industrial Research Natural nontoxic multicolor fluorescent protein dye from a marine invertebrate, compositions containing the said dye and its uses
US6689391B2 (en) 2001-03-30 2004-02-10 Council Of Scientific & Industrial Research Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses
US6956122B2 (en) * 2001-09-05 2005-10-18 Council Of Scientific & Industrial Research Multiple fluorescent natural dye compound from a marine organism
US20030175854A1 (en) * 2002-02-28 2003-09-18 Kayser Kevin J. System and method for gene expression in thermus strains
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
AU2003256982A1 (en) * 2002-07-29 2004-02-16 Cardax Pharmaceuticals, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
US20070082066A1 (en) * 2003-05-07 2007-04-12 Gierhart Dennis L Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity
AU2004274750B2 (en) * 2003-09-17 2007-05-17 Nippon Oil Corporation Process for producing carotenoid compound
US7941211B2 (en) * 2003-11-17 2011-05-10 Zeavision, Llc. Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
US20050214898A1 (en) * 2004-03-29 2005-09-29 Bernstein Paul S Methods of carotenoid production in bacteria
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005102356A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060089411A1 (en) * 2004-08-07 2006-04-27 Gierhart Dennis L Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
US20060155150A1 (en) * 2004-10-01 2006-07-13 Lockwood Samuel F Methods for the synthesis of lutein
KR101482081B1 (ko) * 2005-03-18 2015-01-13 마이크로비아 인크. 유질 효모와 진균 내에서 카로티노이드의 생산
KR100635980B1 (ko) 2005-04-29 2006-10-18 고려대학교 산학협력단 통계적 최적화 방법과 화학물질의 유도에 따른크산토필로마이세스 덴드로로스 jh1 돌연변이체를 이용한아스타잔틴 대량생산방법
WO2007114461A1 (ja) 2006-03-28 2007-10-11 Asahi Kasei Pharma Corporation カロテノイドの製造方法
EP2078092A2 (de) 2006-09-28 2009-07-15 Microbia, Inc. Herstellung von carotenoiden in öliger hefe und pilzen
JP4969370B2 (ja) * 2007-08-29 2012-07-04 Jx日鉱日石エネルギー株式会社 カロテノイドの製造方法
ES2330602B1 (es) * 2008-03-19 2010-09-30 Vitatene, S.A Metodo de produccion de fitoeno y/o fitoflueno, o mezclas de carotenoides con alto contenido en los mismos.
WO2009147673A1 (en) * 2008-06-03 2009-12-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Bacteria expressing a sequestration and secretion pathway from paracoccus marcusii and uses thereof
JP5714907B2 (ja) 2008-10-17 2015-05-07 Jx日鉱日石エネルギー株式会社 カロテノイドの発酵法
JP5155898B2 (ja) 2009-01-30 2013-03-06 Jx日鉱日石エネルギー株式会社 カロテノイドの分離法
JP5149837B2 (ja) 2009-02-27 2013-02-20 Jx日鉱日石エネルギー株式会社 カロテノイドの製造方法
JP5762691B2 (ja) 2010-03-15 2015-08-12 Jx日鉱日石エネルギー株式会社 発酵によるアスタキサンチン製造方法
AR095937A1 (es) * 2013-04-05 2015-11-25 Acraf Potenciador de la solubilidad en agua a base de glucógeno
US10947574B2 (en) 2015-12-28 2021-03-16 Eneos Corporation Method for producing fermented carotenoid using carotenoid-producing bacteria obtained by using cobalt-containing culturing medium
JP6357186B2 (ja) 2016-03-31 2018-07-11 Jxtgエネルギー株式会社 カロテノイドの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH549094A (de) * 1970-07-31 1974-05-15 Hoffmann La Roche Verfahren zur herstellung von zeaxanthin.
US3891504A (en) * 1970-07-31 1975-06-24 Hoffmann La Roche Process for the manufacture of zeaxanthin
CH572980A5 (de) * 1973-07-26 1976-02-27 Nestle Sa
CH572981A5 (de) * 1973-07-26 1976-02-27 Nestle Sa
KR0148133B1 (ko) * 1989-08-30 1998-08-01 엘. 기르하르트 데니스 제아키산틴의 제조 및 제아키산틴 함유 조성물

Also Published As

Publication number Publication date
NO942731L (no) 1995-01-23
DE69425706T2 (de) 2001-05-03
NO942731D0 (no) 1994-07-21
EP0635576B1 (de) 2000-08-30
NO313204B1 (no) 2002-08-26
EP0635576A1 (de) 1995-01-25
CA2128549C (en) 2010-03-09
US5607839A (en) 1997-03-04
US5858761A (en) 1999-01-12
CA2128549A1 (en) 1995-01-23

Similar Documents

Publication Publication Date Title
DE69425706D1 (de) Bakterium neuer Art und Verfahren zur Herstellung von Carotenoiden unter Verwendung dieses Bakteriums
DE69418851T2 (de) Verfahren zur Herstellung von Befestigungsvorrichtungen
DE69632246D1 (de) Verfahren zur herstellung von befestigungselementen und entsprechendes befestigungselement
DE59709793D1 (de) Kunststoff-recyclingverfahren und verfahren zur herstellung von kunststoffwerkstoffen
DE59609850D1 (de) Verfahren zur Herstellung von Vanillin und dafür geeignete Mikroorganismen
DE69223039D1 (de) Pneumatische Pulverisierungsvorrichtung und Verfahren zur Herstellung von Toner
DE69422812D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan und/oder 1,1,3,3,3-pentafluorpropen
ATE219767T1 (de) Verfahren zur herstellung von 2,4-dihydroxy- pyridin und 2,4-dihydroxy-3-nitropyridin
DE68928351D1 (de) Verfahren zur Herstellung von Polymerteilchen, Verfahren zur Herstellung von "Toner"-teilchen, und durch dieses Verfahren hergestellte Teilchen
DE59206250D1 (de) Bauelement und Verfahren zur Herstellung dieses Bauelements
ATA9493A (de) Verwendung und verfahren zur herstellung von n-cyclischen und n,n'-dicyclischen harnstoffen
DE69613964D1 (de) Verfahren zur herstellung von pentafluoroethan und tetrafluorochloroethan
DE69321848D1 (de) Verfahren zur herstellung von 1,1,1,2,3,3-hexafluorpropan und von tetrafluorchlorpropen
DE69424948D1 (de) Verfahren zur herstellung von fluorierten propanen und pentanen
DE69229561D1 (de) Vorverstärkungsverfahren zur herstellung von verbundfluorpolymeren
DE69525415D1 (de) Schrumpfbarer Schlauch, aus Verbundmaterial, und Verfahren zur Abdichtung unter Verwendung dieses Schlauches
DE59606567D1 (de) Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren
DE59705188D1 (de) Verbessertes verfahren zur herstellung von halogenmethylcyclopropanen und besonders reine halogenmethylcyclopropane
ATE148446T1 (de) Verfahren zur herstellung von 2- alkoxymethylakrolein und seine verwendung zur herstellung von 3-alkoxymethylchinolinen
DE59401257D1 (de) Verfahren zur Herstellung eines modifizierten Polytetrafluorethylens und seine Verwendung
DE69431396D1 (de) Verfahren zur herstellung von n-tert-butyl-2-pyrazincarboxamid und n-tert-butyl-2-piperazincarboxamid
DE59710427D1 (de) Verfahren zur herstellung und dispergieren von alumosilikaten
DE3685337D1 (de) Verfahren zur herstellung von amiden unter verwendung von mikroorganismen.
DE69419516D1 (de) Verfahren zur herstellung von hexafluorocyclobuten und verfahren zur herstellung von hexafluorocyclobutan
DE69718171T2 (de) Verfahren zur herstellung von diiod flourverbindungen unter verwendung von cf2i2 und olefinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition